ConductScience.org, home

Paper42294271

Synergistic anticancer effect of ellagic acid and Kaempferol combination in a mouse model of breast cancer.

Shihab RJ and 5 others. Front Oncol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Synergistic anticancer effect of ellagic acid and Kaempferol combination in a mouse model of breast cancer. Papers, record 42294271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42294271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synergistic anticancer effect of ellagic acid and Kaempferol combination in a mouse model of breast cancer.
PubMed
Journal
Front Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shihab RJRand Jabbar
2Alasmari MMMoudi M
3Alshaeri HKHeba K
4Hock MMárta
5Talib WHWamidh H
6Ostojic SSergej

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129566160Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice.J Antimicrob Chemother2018https://conductscience.org/library/papers/29566160PubMed
226974372Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells.Eur J Med Chem2016https://conductscience.org/library/papers/26974372PubMed
336084384Current and future burden of breast cancer: Global statistics for 2020 and 2040.Breast2022https://conductscience.org/library/papers/36084384PubMed
435814435Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.Front Oncol2022https://conductscience.org/library/papers/35814435PubMed
526418626Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria.Redox Biol2015https://conductscience.org/library/papers/26418626PubMed
634250022The Role of Tumour Metabolism in Cisplatin Resistance.Front Mol Biosci2021https://conductscience.org/library/papers/34250022PubMed
735995378Protective activities of ellagic acid and urolithins against kidney toxicity of environmental pollutants: A review.Environ Toxicol Pharmacol2022https://conductscience.org/library/papers/35995378PubMed
828258039Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways.Biomed Pharmacother2017https://conductscience.org/library/papers/28258039PubMed
931273920Kaempferol attenuates liver fibrosis by inhibiting activin receptor-like kinase 5.J Cell Mol Med2019https://conductscience.org/library/papers/31273920PubMed
1029896225Ellagic acid induces HeLa cell apoptosis via regulating signal transducer and activator of transcription 3 signaling.Exp Ther Med2018https://conductscience.org/library/papers/29896225PubMed
1126852623Natural Products as Sources of New Drugs from 1981 to 2014.J Nat Prod2016https://conductscience.org/library/papers/26852623PubMed
1216381622The global breast cancer burden: variations in epidemiology and survival.Clin Breast Cancer2005https://conductscience.org/library/papers/16381622PubMed
1339316086Kaempferol attenuates cyclosporine-induced renal tubular injury via inhibiting the ROS-ASK1-MAPK pathway.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39316086PubMed
1423689461Estimation of rat mammary tumor volume using caliper and ultrasonography measurements.Lab Anim (NY)2013https://conductscience.org/library/papers/23689461PubMed
1535468008Kaempferol: A flavonoid with wider biological activities and its applications.Crit Rev Food Sci Nutr2023https://conductscience.org/library/papers/35468008PubMed
1635733130Anti-tumor and antioxidant activity of kaempferol-3-O-alpha-L-rhamnoside (Afzelin) isolated from Pithecellobium dulce leaves.BMC Complement Med Ther2022https://conductscience.org/library/papers/35733130PubMed
1732640518Antioxidative Action of Ellagic Acid-A Kinetic DFT Study.Antioxidants (Basel)2020https://conductscience.org/library/papers/32640518PubMed
1834278281Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns.EClinicalMedicine2021https://conductscience.org/library/papers/34278281PubMed
1935986346A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound.Cancer Cell Int2022https://conductscience.org/library/papers/35986346PubMed
2033845796Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.BMC Cancer2021https://conductscience.org/library/papers/33845796PubMed

See all 50 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42582442Potent Therapeutic Insights From Eryngium campestre: Phytochemical Profiling and In Vitro Evaluation.Food Sci Nutr2026https://conductscience.org/library/papers/42582442

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42294271

GET https://conductscience.org/api/papers/v1/42294271/references?page=2